B+
Bull case
25%
Probability
Target price
$12.50
Analysis reference price unavailable
Analysis 2026-10-02 · RankAlpha Sentiment Codex
ALHC
Alignment HealthcareDNasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment CodexMost likely
B
Base case
45%
Probability
Target price
$8.40
Analysis reference price unavailable
Analysis 2026-10-02 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$4.80
Analysis reference price unavailable
Analysis 2026-10-02 · RankAlpha Sentiment Codex
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2026-10-02
Recent news sentiment (30D)
-26.0
Negative
Company
-
Unavailable
Macro
-26.0
Negative
Pulse
-
Unavailable
Weekly research (10D)
-
Unavailable
Sentiment proxy
+61.3
Score
AI commentary
The October 1 $7.74 anchor is substantially below the $13.68 price cited in a September 4 secondary article, but that comparison does not establish the cause of the decline. The October 1 company expansion announcement adds a concrete forward hook; enrollment and margin results remain unproven. Verified post-selloff analyst revisions and dependable social, options, short-interest and employee measures are unavailable; zero sentiment fields mean missing data, not neutral readings.
RankAlpha Sentiment Codex - 2026-10-02
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-10-31event2027 Medicare Advantage Star RatingsHigh impact
The forthcoming ratings could change the outlook for future quality-bonus economics. Alignment identifies maintaining high plan ratings as a material risk; a downgrade is not confirmed. [#8-K-2026-07-30] Company Q2 release CMS ratings policy
2026-11-15eventQ3 results test medical-cost controlHigh impact
After Q2 revenue of $1.336 billion and approximately 294,100 members, company Q3 guidance calls for $1.30–$1.32 billion of revenue and $20–$30 million of adjusted EBITDA. Delivery against those ranges is the next operating test; the result date is an estimate, not a company-announced date. [#8-K-2026-07-30] [#IR-Q2-2026-07-30] Company Q2 release
2027-01-01eventEnrollment test for the expanded 2027 plan portfolioHigh impact
Alignment announced 77 plans across 55 counties for 2027, including 10 new counties, with annual enrollment running October 15–December 7. The opportunity is disclosed, but enrollment and medical-cost outcomes are not yet known. [#IR-2026-10-01] Company announcement
Recommendation
N/A
No formal recommendation provided.
As of 2026-10-02 • Updated nightlySource: Internal modelMethodology